Compounds > fluprednisolone
Page last updated: 2024-11-07

fluprednisolone and Obesity

fluprednisolone has been researched along with Obesity in 2 studies

Fluprednisolone: A synthetic glucocorticoid with anti-inflammatory properties.

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
EXLEY, D1
NORYMBERSKI, JK1
HOLDEN, G1
KENDALL, PH1

Other Studies

2 other studies available for fluprednisolone and Obesity

ArticleYear
URINARY EXCRETION OF 17-DEOXYCORTICOSTEROIDS BY MAN.
    The Journal of endocrinology, 1964, Volume: 29

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Addison Disease; Adrenal Insufficiency; Aging; Cushing S

1964
A NEW SYNTHETIC CORTICOSTEROID--P.1742.
    Annals of physical medicine, 1964, Volume: 8

    Topics: Adrenal Cortex Hormones; Arthritis; Arthritis, Rheumatoid; Drug Therapy; Dyspepsia; Fluprednisolone;

1964